Behavioral Pharmacology of AR-A000002, a Novel, Selective 5-Hydroxytryptamine1B Antagonist

@article{Hudzik2003BehavioralPO,
  title={Behavioral Pharmacology of AR-A000002, a Novel, Selective 5-Hydroxytryptamine1B Antagonist},
  author={Thomas J Hudzik and M. Yanek and T. Porrey and John Evenden and Carol A. Paronis and Mary Ann Mastrang{\`e}lo and Christine N. Ryan and Svante B. Ross and Carina Stenfors},
  journal={Journal of Pharmacology and Experimental Therapeutics},
  year={2003},
  volume={304},
  pages={1072 - 1084}
}
The present review summarizes the behavioral pharmacology conducted to profile the anxiolytic and antidepressant potential of the selective 5-hydroxytryptamine (HT)1B antagonist (R)-N-[5-methyl-8-(4-methylpiperazin-1-yl)-1,2,3,4-tetrahydro-2-naphthyl]-4-morpholinobenzamide (AR-A000002). AR-A000002 functions as a 5-HT1B antagonist in vivo, which was shown by the antagonism of the discriminative stimulus effects in the guinea pig of the 5-HT1B agonist 3-(N-methylpyrrolidin-2R-ylmethyl)-5-(3… 

Pharmacology of a novel selective 5-hydroxytryptamine1B receptor antagonist, AR-A000002

It is concluded that AR-A000002 is a 5-HT1B receptor antagonist that enhances the serotonergic neurotransmission in guinea pig brain and the terminal 5- HT1B autoreceptors are tonically activated under drug-free as well as citalopram conditions.

Characterization of the potent 5-HT(1A/B) receptor antagonist and serotonin reuptake inhibitor SB-649915: preclinical evidence for hastened onset of antidepressant/anxiolytic efficacy.

SB-649915 is a novel, potent 5- HT1A/1B autoreceptor antagonist, and 5-HT reuptake inhibitor that demonstrated acute anxiolytic activity in both rodent and non-human primate and reduced the latency to onset of anxioleytic behavior, compared to paroxetine, in the rat social interaction paradigm.

Effects of long-term administration of the 5-hydroxytryptamine1B receptor antagonist AR-A000002 to guinea pigs

It is concluded that AR-A000002 is a 5-HT1B receptor antagonist, which enhances persistently the serotonergic neurotransmission in guinea pig brain.

Effects of a selective 5-HT1B receptor agonist and antagonists in animal models of anxiety and depression

The results indicate that the selective agonist (CP 94253) and antagonists (SB 216641 and GR 127935) of 5-HT1B receptors produce effects that are characteristic of anxiolytics, in the preclinical models used; however, CP 94253 also behaves like an antidepressant drug.

[N-methyl-3H3]AZ10419369 Binding to the 5-HT1B Receptor: In Vitro Characterization and in Vivo Receptor Occupancy

In vitro and in vivo evaluation of tritiated 5- methyl-8-(4-methyl-piperazin-1-yl)-4-oxo-4H-chromene-2-carboxylicacid (4-morpholin-4-yl-phenyl)-amide, a potent 5-HT1B radiotracer, show it is a useful preclinical tool for investigating 5- HT1B receptor occupancy for novel compounds targeting this receptor.

Chronic treatment with duloxetine is necessary for an anxiolytic-like response in the mouse zero maze: the role of the serotonin transporter

Duloxetine was anxiolytic after chronic but not acute treatment, reflecting clinical experience with antidepressants in general, and may be ascribed to the considerable reduction in the density of the SERT in the cortex.

References

SHOWING 1-10 OF 55 REFERENCES

CP-135,807, a selective 5-HT1D agonist: effects in drug discrimination and punishment procedures in the pigeon

Results suggest that CP-135,807 produces centrally mediated psychoactive effects that differ distinctly from those of 5-HT1A agonists.

Antidepressant-like effects of 5-hydroxytryptamine1A receptor agonists on operant responding under a response duration differentiation schedule.

It was found that propranolol, trazodone, and both the full and partial 5-HT1A agonists produced increases in the mean response duration, which is typical of antidepressant activity, while compounds lacking antidepressant efficacy failed to produce increases in mean response durations.

Serotonin autoreceptor in rat hippocampus: Pharmacological characterization as a subtype of the 5-HT1 receptor

5-HT nerve terminals of rat hippocampus possess autoreceptors which appear to belong to the 5-HT1B subtype, which is characterized pharmacologically in terms of 5- HT receptor subtype by using superfused synaptosomes depolarized with 15 mM KCl.

Synergism between 5-HT1B/1D and 5-HT1A receptor antagonists on turnover and release of 5-HT in guinea-pig brain in vivo

Extracellular 5-HIAA seems to be a better marker than 5-HT itself for the evoked5-HT release when the reuptake mechanism is intact and the synergistic effect of the two receptor antagonists on the 5-ht turnover and the terminal release of 5- HT indicate somatodendritic 5-HCIAA release and stimulation of inhibitory 6-HT1A receptors at this level.

Anxiolytic and antidepressant mechanisms of 5-HT1A drugs in the pigeon: Contributions from behavioral studies

Identity of inhibitory presynaptic 5-hydroxytryptamine (5-HT) autoreceptors in the rat brain cortex with 5-HT1B binding sites

In rat brain cortex slices preincubated with [3H]5-HT, the evidence indicates that the presynaptic 5- HT autoreceptor belongs to the 5-HT1B receptor subtype.

A comparison of the effects of diazepam versus several typical and atypical anti-depressant drugs in an animal model of anxiety

It is suggested that a variety of tricyclic and novel anti-depressant drugs acquire anxiolytic properties following chronic administration.

5-HT1A agonist effects on punished responding of squirrel monkeys

...